You have 9 free searches left this month | for more free features.

edoxaban

Showing 1 - 25 of 208

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thrombosis, Venous, Cancer, Catheter Complications Trial in Beijing (Edoxaban)

Not yet recruiting
  • Thrombosis, Venous
  • +2 more
  • Edoxaban
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Nov 20, 2023

Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])

Not yet recruiting
  • Liver Cirrhosis
  • Apixaban 5 MG [Eliquis]
  • Edoxaban 60 MG [Lixiana]
  • (no location specified)
May 19, 2023

CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )

Active, not recruiting
  • CTEPH
  • Edoxaban
  • +3 more
  • Fukuoka, Japan
    Kyushu University Hospital
Aug 30, 2022

Anticoagulant Therapy Trial in Mannheim (Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab)

Active, not recruiting
  • Anticoagulant Therapy
  • Apixaban 5 MG Tab
  • +3 more
  • Mannheim, Germany
    Clincial Research Serivces
Aug 4, 2022

Atrial Fibrillation Trial in Padova

Completed
  • Atrial Fibrillation
    • Padova, Italy
      Padua University Hospital
    Aug 6, 2022

    Non-Valvular Atrial Fibrillation Trial in Beijing (Edoxaban)

    Recruiting
    • Non-Valvular Atrial Fibrillation
    • Edoxaban
    • Beijing, Beijing, China
      Fuwai Hospital, Chinese Academy of Medical Sciences
    Jun 14, 2022

    Routine Clinical Practice for Non-valvular Atrial Fibrillation

    Completed
    • Atrial Fibrillation
    • Edoxaban
    • Hong Kong, Hong Kong
    • +3 more
    Aug 17, 2022

    Determining Clinical Relevance of Interaction Between

    Recruiting
    • Drug-drug Interaction
    • Blood sampling - Pharmacokinetic assessment
    • Nijmegen, Netherlands
    • +2 more
    Oct 26, 2022

    Mitral Valve Stenosis, Atrial Fibrillation, Stroke Trial in Korea, Republic of (Edoxaban, Warfarin)

    Recruiting
    • Mitral Valve Stenosis
    • +3 more
    • Seoul, Seocho-gu, Korea, Republic of
    • +6 more
    Sep 12, 2022

    Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)

    Active, not recruiting
    • Venous Thrombosis
    • +2 more
    • 12-month Edoxaban
    • 3-month Edoxaban
    • Kyoto, Japan
      Department of Cardiovascular Medicine, Kyoto University Graduate
    Aug 16, 2022

    Routine Clinical Practice for Non-Valvular Atrial Fibrillation

    Completed
    • Atrial Fibrillation
    • Edoxaban
    • Khon Kaen, Muang District, Thailand
    • +5 more
    May 5, 2022

    Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or

    Recruiting
    • Covid19
    • Anticoagulation Agents (Edoxaban and/or high dose LMWH)
    • Low dose Low molecular weight heparin or Placebo
    • Aachen, Germany
    • +9 more
    May 16, 2022

    Ischemic Stroke, Atrial Fibrillation, Hemorrhagic Transformation Stroke Trial in Edmonton (Edoxaban 60 MG, Edoxaban 30 mg)

    Recruiting
    • Ischemic Stroke
    • +2 more
    • Edoxaban 60 MG
    • Edoxaban 30 mg
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 6, 2022

    Atrial Fibrillation and Flutter, Valvular Heart Disease Trial in Canada (Edoxaban Pill)

    Recruiting
    • Atrial Fibrillation and Flutter
    • Valvular Heart Disease
    • Edoxaban Pill
    • Granby, Quebec, Canada
    • +7 more
    Feb 2, 2022

    SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)

    Recruiting
    • SCAD
    • AMI
    • Sao Paulo, Brazil
      Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
    Nov 4, 2021

    Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)

    Recruiting
    • Ischemic Stroke
    • Anticoagulant Adverse Reaction
    • Dabigatran, rivaroxaban, apixaban, edoxaban
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 22, 2023

    Auricular Fibrillation Trial in Spain (Edoxaban)

    Recruiting
    • Auricular Fibrillation
    • Edoxaban
    • Elche, Alicante, Spain
    • +32 more
    Feb 16, 2023

    Anticoagulation in Venous Thromboembolism and Cancer

    Active, not recruiting
    • Neoplasms
    • Embolism
    • London, United Kingdom
      Pfizer Investigational Site
    Nov 17, 2022

    Edoxaban in Patients 80 Years of Age or Older With Nonvalvular

    Recruiting
    • Atrial Fibrillation
    • Edoxaban
    • Ansan, Korea, Republic of
    • +29 more
    Apr 6, 2023

    Atrial Fibrillation, Left Atrial Appendage Thrombosis Trial in Korea, Republic of (Edoxaban)

    Recruiting
    • Atrial Fibrillation
    • Left Atrial Appendage Thrombosis
    • Edoxaban
    • Daegu, Korea, Republic of
    • +11 more
    Mar 12, 2022

    Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)

    Recruiting
    • Bleeding Post Cardiac Surgery
    • Indication for Anticoagulation
    • Hamilton, Ontario, Canada
      Hamilton General Hospital
    Oct 31, 2022

    Healthy Trial (Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg)

    Not yet recruiting
    • Healthy
    • Tegoprazan 50mg
    • +3 more
    • (no location specified)
    Feb 2, 2023

    Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)

    Recruiting
    • Atrial Fibrillation
    • Recurrent Venous Thromboembolism
    • dabigatran, rivaroxaban, apixaban or edoxaban
    • Barcelona, Catalonia, Spain
      Hospital de la Santa Creu i Sant Pau
    Apr 27, 2022

    Anticoagulation Length of ThErapy and Risk of New Adverse evenTs

    Completed
    • Venous Thromboembolism
    • Anticoagulants and Bleeding Disorders
    • Oral Anticoagulant
    • Oakland, California
    • +1 more
    Oct 31, 2022

    Oral Anti-coagulants in Fragile Percutaneous Endoscopic

    Completed
    • Atrial Fibrillation
    • Edoxaban
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Oct 25, 2021